Clinical evaluation on the pain-reducing effect of Aconinsan for burning mouth syndrome
Not Applicable
- Conditions
- Burning mouth syndrome
- Registration Number
- JPRN-UMIN000044521
- Lead Sponsor
- Saga University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient suffer from Angle-closure Glaucoma 2)Patient have medical history of hypersensivity to prescription drug 3)Patient have medical history of cardiovascular disease and cerebrovascular disorder 4)Patient suffer from prostate disease 5)Patient who administered MAOI 6)Patient suffer from hyperthyroidism 7)Patient suffer from convulsive disorder 8)Patient suffer from manic depression 9)Patients with organic brain disorders or predisposition to schizophrenia 10)Patients who have or have had suicidal thoughts or suicide attempts 11)Patients taking other antidepressants, anti-epileptic drugs, anti-anxiety drugs, etc. 12)Patient who is judged inappropriate by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of pain improvement by VAS after 3 months of treatment
- Secondary Outcome Measures
Name Time Method